- « Previous
- Clinical Pharmacology
- Next »
Ceclor
Clinical Pharmacology
Ceclor
Note:β-lactamase-negative, ampicillin-resistant strains of H. influenzae should be considered resistant to cefaclor despite apparent in vitro susceptibility to this agent.
A report of "Susceptible" indicates that the pathogen is likely to be inhibited by usually achievable concentrations of the antimicrobial compound in blood. A report of "Intermediate" indicates that the result should be considered equivocal, and, if the microorganism is not fully susceptible to alternative, clinically feasible drugs, the test should be repeated. This category implies possible clinical applicability in body sites where the drug is physiologically concentrated or in situations where high dosage of drug can be used. This category also provides a buffer zone that prevents small uncontrolled technical factors from causing major discrepancies in interpretation. A report of "Resistant" indicates that usually achievable concentrations of the antimicrobial compound in the blood are unlikely to be inhibitory and that other therapy should be selected.
Standardized susceptibility test procedures require the use of laboratory control microorganisms. Standard cefaclor powder should provide the following MIC values:
| Microorganism | MIC (µg/mL) | |
| E. coli | ATCC 25922 | 1-4 |
| E. faecalis | ATCC 29212 | > 32 |
| S. aureus | ATCC 29213 | 1-4 |
| When testing H. influenzae* | ||
| Microorganism | MIC (µg/mL) | |
| H. influenzae | ATCC 49766 | 1-4 |
| *Broth microdilution test performed using Haemophilus Test Medium (HTM)1 | ||
Diffusion Techniques — Quantitative methods that require measurement of zone diameters provide reproducible estimates of the susceptibility of bacteria to antimicrobial compounds. One such standardized procedure2 that has been recommended for use with disks to test the susceptibility of microorganisms to cefaclor uses the 30-µg cefaclor disk. Interpretation involves correlation of the diameter obtained in the disk test with the MIC for cefaclor. Reports from the laboratory providing results of the standard single-disk susceptibility test with a 30-µg cefaclor disk should be interpreted according to the following criteria:
When Testing Organisms Other Than Haemophilus spp. and Streptococci
| Zone Diameter (mm) | Interpretation |
| ≥ 18 | Susceptible (S) |
| 15-17 | Intermediate (I) |
| ≤ 14 | Resistant (R) |
When testing H. influenzae*
| Zone Diameter (mm) | Interpretation |
| ≥ 20 | Susceptible (S) |
| 17-19 | Intermediate (I) |
| ≤ 16 | Resistant (R) |
| *Disk susceptibility test performed using Haemophilus Test Medium (HTM)2 | |
Note: β-lactamase-negative, ampicillin-resistant strains of H. influenzae should be considered resistant to cefaclor despite apparent in vitro susceptibility to this agent.
Interpretation should be as stated above for results using dilution techniques.
As with standard dilution techniques, diffusion methods require the use of laboratory control microorganisms. The 30-µg cefaclor disk should provide the following zone diameters in these laboratory test quality control strains:
| Microorganism | Zone Diameter (mm) |
| E. coli ATCC 25922 | 23-27 |
| S. aureus ATCC 25923 | 27-31 |
When testing H. influenzae*
| Microorganism | Zone Diameter (mm) | |
| H. influenzae | ATCC 49766 | 25-31 |
| *Disk susceptibility test performed using Haemophilus Test Medium (HTM)2 | ||
REFERENCES
1. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically — Fourth Edition. Approved Standard NCCLS Document M7-A4, Vol. 17, No. 2, NCCLS, Wayne, PA, January, 1997.
2. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests — Sixth Edition. Approved Standard NCCLS Document M2-A6, Vol. 17, No. 1, NCCLS, Wayne, PA, January, 1997.
Generic Name: Cefaclor
- « Previous
- Clinical Pharmacology
- Next »
Herbal First Aid
Herbal medicine is ancient, but only in recent years have many people started to take notice of its all natural healing powers. See more WebMD Videos »
WebMD Daily
Get breaking medical news.
